Skip to main content

RBD, Antidepressant Medications, and Psychiatric Disorders

  • Chapter
  • First Online:

Abstract

Idiopathic RBD (iRBD), co-morbid psychiatric illnesses, and the use of psychotropics have been increasingly reported in the literature. Among the iRBD patients, depression was found to be a common co-morbid condition. Cohorts of iRBD patients reported that those taking antidepressants were associated with significant abnormalities of early neurodegenerative markers. In a Chinese cohort, depression was found to have an increased risk of conversion to Parkinson’s disease. On the other hand, RBD symptoms have been reported in patients with psychiatric illnesses (pRBD), such as depression and post-traumatic stress disorders. This pRBD group of subjects was mostly of younger age, a higher prevalence of female gender, albeit they had a similar degree of sleep-related injuries to that of typical iRBD. While the previous literature used to regard it as an iatrogenic condition induced by antidepressants, more evidence from case-control studies, cohort studies and neuroimaging results suggested that it could be a complex condition. Apart from the drug effect, it is likely that the psychiatric illnesses per se, with a possibility of underlying neurodegeneration, could contribute to the development of RBD symptoms. Further study will need to determine the outcome of pRBD, their underlying neural circuitry, and neurotransmitter abnormalities.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2000;123:331–9.

    Article  Google Scholar 

  2. Schenck CH, Mahowald MW. REM sleep behaviour disorder: clinical developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep. 2002;25:120–38.

    Article  Google Scholar 

  3. Wing YK, Lam SP, Li SX, Yu MW, Fong SY, Tsoh JM, et al. REM sleep behavior disorder in Hong Kong Chinese: clinical outcome and gender comparison. J Neurol Neurosurg Psychiatry. 2008;79:1415–6.

    Article  CAS  Google Scholar 

  4. Teman PT, Tippmann-Peikert M, Silber MH, Slocumb NL, Auger RR. Idiopathic rapid-eye-movement sleep disorder: associations with antidepressants, psychiatric diagnoses, and other factors in relation to age of onset. Sleep Med. 2009;10:60–5.

    Article  Google Scholar 

  5. Frauscher B, Gschliesser V, Brandauer E, Marti I, Furtner MT, Ulmer H, et al. REM sleep behavior disorder in 703 sleep-disorder patients: the importance of eliciting a comprehensive sleep history. Sleep Med. 2010;11:167–71.

    Article  Google Scholar 

  6. Frauscher B, Jennum P, Ju YE, Postuma RB, Arnulf I, Cochen V, et al. Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study. Neurology. 2014;82:1076–9.

    Article  Google Scholar 

  7. Bonakis A, Howard RS, Ebrahim IO, Merritt S, Williams A. REM sleep behavior disorder and its associations in young patients. Sleep Med. 2009;10:641–9.

    Article  Google Scholar 

  8. Ju YE, Larson-Prior L, Duntley S. Changing demographics in REM sleep behavior disorder: possible effect of autoimmunity and antidepressants. Sleep Med. 2011;12:278–83.

    Article  Google Scholar 

  9. Yu YE. Rapid eye movement sleep behavior disorder in adults younger than 50 years of age. Sleep Med. 2013;14:768–74.

    Article  Google Scholar 

  10. Lam SP, Fong SYY, Ho CKW, Yu MW, Wing YK. Parasomnia among psychiatric outpatients: a clinical, epidemiologic, cross-sectional survey. J Clin Psychiatry. 2008;69:1374–82.

    Article  Google Scholar 

  11. Lam SP, Li SX, Chan JWY, Mok V, Tsoh J, Chan A, et al. Does rapid eye movement sleep behavior disorder exist in psychiatric populations? A clinical and polysomnographic case-control study. Sleep Med. 2013;14:788–94.

    Article  Google Scholar 

  12. Li SX, Wing YK, Lam SP, Zhang J, Yu MW, Ho CK, et al. Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK). Sleep Med. 2010;11:43–8.

    Article  CAS  Google Scholar 

  13. Mysliwiec V, O’Reilly B, Polchinski J, Kwon HP, Germain A, Roth BJ. Trauma associated sleep disorder: a proposed parasomnia encompassing disruptive nocturnal behaviors nightmares, and REM without atonia in trauma survivors. J Clin Sleep Med. 2014;10:1143–8.

    PubMed  PubMed Central  Google Scholar 

  14. Sheyner I, Khan S, Stewart JT. A case of selective serotonin reuptake inhibitor-induced rapid eye movement behavior disorder. J Am Geriatr Soc. 2010;58(7):1421–2.

    Article  Google Scholar 

  15. Thordarodottir EB, Hansdottir I, Valdimarsdottir UA, Shiperd JC, Resnick H, Gudmundsdottir B. The manifestations of sleep disturbances 16 years post-trauma. Sleep. 2016;39:1551–4.

    Article  Google Scholar 

  16. Husain AM, Miller PP, Carwile ST. REM sleep behavior disorder: potential relationship to post-traumatic disorder. J Clin Neurophysiol. 2001;18:148–57.

    Article  CAS  Google Scholar 

  17. Ross RJ, Ball WA, Dinges DF, Kribbs NB, Morrison AR, Silver SM, et al. Motor dysfunction during sleep in posttraumatic stress disorder. Sleep. 1994;17:723–32.

    Article  CAS  Google Scholar 

  18. Schenck CH, Hurwitz TD, Mahowald MW. REM sleep behavior disorder. Am J Psychiatry. 1988;145:662.

    Google Scholar 

  19. Hefez A, Metz L, Lavie P. Long-term effects of extreme situational stress on sleep and dreaming. Am J Psychiatry. 1987;144:344–7.

    Article  CAS  Google Scholar 

  20. Akindele MO, Evans J, Oswalk I. Monoamine oxidase inhibitors and sleep. Electroencephalogr Clin Neurophysiol. 1970;28:429.

    PubMed  CAS  Google Scholar 

  21. Hoque R, Chesson AL. Pharmacologically induced/exacerbated restless leg syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med. 2010;6:79–83.

    PubMed  PubMed Central  Google Scholar 

  22. Onofrj M, Luciano AL, Thomas A, Lacono D, D’Andreamatteo G. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology. 2003;60:1113–5, 113.

    Article  Google Scholar 

  23. Parish JM. Violent dreaming and antidepressant drugs: or how paroxetine made me dream that I was fighting Saddam Hussein. J Clin Sleep Med. 2007;3(5):529–31.

    PubMed  PubMed Central  Google Scholar 

  24. Schenck CH, Mahowald MW, Kin SW, O’Connor KA, Hurwitz TD. Prominent eye movements during NREW sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep. 1992;15:226–35.

    Article  CAS  Google Scholar 

  25. Schutte S, Doghramji K. REM behavior disorder seen with venlafaxine. Sleep Res. 1996;25:364.

    Google Scholar 

  26. Lam SP, Zhang J, Tsoh J, Li SX, Ho CKW, Mok V, et al. REM sleep behavior disorder in psychiatric populations. J Clin Psychiatry. 2010;71:1101–3.

    Article  Google Scholar 

  27. Winkelman JW, James L. Serotonergic antidepressants are associated with REM sleep without atonia. Sleep. 2004;27:317–21.

    Article  Google Scholar 

  28. Zhang B, Hao Y, Jia F, Tang Y, Li X, Liu W, Arnulf I. Sertraline and rapid eye movement sleep without atonia: an 8-week, open-label study of depressed patients. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;47:85–92.

    Article  CAS  Google Scholar 

  29. McCarter S, St. Louis EK, Sandness DJ, Arndt KA, Erickson MK, Tabatabai GM. Antidepressants increase REM sleep muscle tone in patients with and without REM sleep behavior disorder. Sleep. 2015;38:907–17.

    PubMed  PubMed Central  Google Scholar 

  30. Lee K, Baron K, Soca R, Attarian H. The prevalence and characteristics of REM sleep without atonia in patients taking antidepressants. J Clin Sleep Med. 2016;12:351–5.

    Article  Google Scholar 

  31. Peever J, Luppi PH, Montplaisir J. Breakdown in REM sleep circuitry underlies REM sleep behavior disorder. Trends Neurosci. 2014;37(5):279–88.

    Article  CAS  Google Scholar 

  32. Arango V, Underwood MD, Mann JJ. Fewer pigmented locus coeruleus neurons in suicide victims. Preliminary results. Biol Psychiatry. 1996;39:112–20.

    Article  CAS  Google Scholar 

  33. Freeman T, Karson C, Garcia-Rill E. Locus coeruleus neuropathology in anxiety disorders. Biol Psychiatry. 1993;33:148A.

    Google Scholar 

  34. Garcia-Rill E. Disorders of the reticular activating system. Med Hypotheses. 1997;49:379–87.

    Article  CAS  Google Scholar 

  35. Ressler KJ, Nemeroff CB. Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol Psychiatry. 1999;46:1219–33.

    Article  CAS  Google Scholar 

  36. Wing YK, Lam SP, Zhang J, Leung E, Ho CL, Chen S, et al. Reduced striatal dopamine transmission in REM sleep behavior disorder comorbid with depression. Neurology. 2015;84:516–22.

    Article  CAS  Google Scholar 

  37. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EV, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24:197–211.

    Article  Google Scholar 

  38. Espay AJ, LeWitt PA, Kaufmann H. Norepinephrine deficiency in Parkinson’s disease: the case for noradrenergic enhancement. Mov Disord. 2014;29:1710–9.

    Article  CAS  Google Scholar 

  39. Wing YK, Li SX, Mok V, Lam SP, Tsoh J, Chan A, et al. Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2012;83(4):470–1.

    Article  Google Scholar 

  40. Postuma RB, Gagnon JF, Bertrand JA, Genier MD, Montplaisir JY. Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. Neurology. 2015;84:1104–13.

    Article  Google Scholar 

  41. Postuma RB, Gagnon JF, Tuineaig M, Bertrand JA, Latreille V, Desjardins C, Montplaisir JY. Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal. Sleep. 2013;36:1579–85.

    Article  Google Scholar 

  42. Ebrahim IO, Peacock KW. REM sleep behavior disorder-psychiatric presentations: a case series from the United Kingdom. J Clin Sleep Med. 2005;1:43–7.

    PubMed  Google Scholar 

  43. Zhang JH, Li SX, Lam SP, Wing YK. REM sleep behavior disorder and obstructive sleep apnea: does one “evil” make the other less or more “evil”? Sleep Med. 2017;37:216–7. https://doi.org/10.1016/j.sleep.2017.06.013.

    Article  PubMed  Google Scholar 

  44. Aurora RN, et al. Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med. 2010;6:85–95.

    PubMed  PubMed Central  Google Scholar 

  45. Lam SP, Wong CC, Li SX, Zhang JH, Chan JW, Zhou JY, et al. Caring burden of REM sleep behavior disorder- spouses’ health and marital relationship. Sleep Med. 2016;24:40–3.

    Article  CAS  Google Scholar 

Download references

Note Added in Proof:

The following are five recent pertinent publications: (1) Okuda M, Iwamoto K, Miyata S, Torii Y, Iritani S, Ozaki N. Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of REM sleep behavior disorder and 123 I-MIBG cardiac scintigraphy. Psychiatry Clin Neurosci 2018; doi: 10.1111/pcn.12651. (2) Fujishiro H, Okuda M, Iwamoto K, et al. REM sleep without atonia in middle-aged and older psychiatric patients and Lewy body disease: a case series. Int J Geriatr Psychiatry 2017;32:397–406. (3) Tan L, Zhou J, Yang L, Ren R, Zhang Y, Li T, Tang X. Duloxetine-induced rapid eye movement sleep behavior disorder: a case report. BMC Psychiatry 2017;17:372; doi: 10.1186/s12888-017-1535-4. (4) Ryan Williams R, Sandigo G. Venlafaxine-induced REM sleep behavioral disorder presenting as two fractures. Trauma Case Rep 2017;11:18–19. (5) Lee HG, Choi JW, Lee YJ, Jeong DU. Depressed REM sleep behavior disorder patients are less likely to recall enacted dreams than non-depressed ones. Psychiatry Investig 2016;13(2):227–31.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yun Kwok Wing .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lam, S.P., Zhang, J., Li, S.X., Wing, Y.K. (2019). RBD, Antidepressant Medications, and Psychiatric Disorders. In: Schenck, C., Högl, B., Videnovic, A. (eds) Rapid-Eye-Movement Sleep Behavior Disorder. Springer, Cham. https://doi.org/10.1007/978-3-319-90152-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90152-7_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90151-0

  • Online ISBN: 978-3-319-90152-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics